GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD. Levine I, Sekhri S, Schreiber-Stainthorp W, Locke B, et al. Inflamm Bowel Dis 2025;31:467-475.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Levine I, Sekhri S, Schreiber-Stainthorp W, Locke B, et al. GLP-1 Receptor Agonists Confer No Increased Rates of IBD Exacerbation Among Patients With IBD. Inflamm Bowel Dis 2025;31:467-475.
PMID: 39438251